Reality and immortalityneural stem cells for therapies
Jeffrey D Rothstein1
& Evan Y Snyder2
1
J.D.R. is in the Department of Neurology at Johns Hopkins University, Meyer 6-109, 600 N. Wolfe St., Baltimore, Maryland 21287, USA. jrothste@jhmi.edu
2
E.Y.S. is Director of the Program in Developmental and Regenerative Cell Biology, The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, USA. esnyder@burnham.org
The successful immortalization of neural progenitor cells via the overexpression of telomerase prompts several questions for those intending to develop somatic stem cell therapies for neurological disease.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.